Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jens Bollerslev, Stine L Fougner & Jens P Berg. (2009) New directions in pharmacological treatment of acromegaly. Expert Opinion on Investigational Drugs 18:1, pages 13-22.
Read now
Read now
Ferdinand Roelfsema, Nienke R Biermasz, Alberto M Pereira & Johannes A Romijn. (2008) Therapeutic options in the management of acromegaly: focus on lanreotide Autogel. Biologics: Targets and Therapy 2:3, pages 463-479.
Read now
Read now
Articles from other publishers (17)
Swati Sharma, Rashmi Rana, Prem Prakash & Nirmal Kumar Ganguly. (2023) Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. Molecular and Cellular Biochemistry.
Crossref
Crossref
S.M. Hosseini, J. Mohammadnejad, S. Salamat, Z. Beiram Zadeh, M. Tanhaei & S. Ramakrishna. (2023) Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review. Materials Today Chemistry 29, pages 101400.
Crossref
Crossref
Leran Mao, Alan J. Russell & Sheiliza Carmali. (2022) Moving Protein PEGylation from an Art to a Data Science. Bioconjugate Chemistry 33:9, pages 1643-1653.
Crossref
Crossref
Fatemeh Farjadian, Amir Ghasemi, Omid Gohari, Amir Roointan, Mahdi Karimi & Michael R Hamblin. (2019) Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine 14:1, pages 93-126.
Crossref
Crossref
Perihan Elzahhar, Ahmed S. F. Belal, Fatema Elamrawy, Nada A. Helal & Mohamed Ismail Nounou. 2019. Pharmaceutical Nanotechnology. Pharmaceutical Nanotechnology
125
182
.
L. OtvosJr.Jr.. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
131
156
.
Ivan V. Smirnov, Ivan I. Vorobiev, Alexey A. Belogurov, Dmitry D. Genkin, Sergey M. Deyev & Alexander G. Gabibov. 2015. Glyco-Engineering. Glyco-Engineering
389
404
.
Paolo Cappabianca, Luigi Maria Cavallo, Isabella Esposito & Felice Esposito. 2014. Neuroendoscopy. Neuroendoscopy
57
64
.
Antonio Bianchi, Ferdinando Valentini, Raffaella Iuorio, Maurizio Poggi, Roberto Baldelli, Marina Passeri, Antonella Giampietro, Linda Tartaglione, Sabrina Chiloiro, Marialuisa Appetecchia, Patrizia Gargiulo, Andrea Fabbri, Vincenzo Toscano, Alfredo Pontecorvi & Laura De Marinis. (2013) Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes. Journal of Experimental & Clinical Cancer Research 32:1.
Crossref
Crossref
H.B. Lowman. 2013. Encyclopedia of Biological Chemistry. Encyclopedia of Biological Chemistry
431
436
.
Nate Larson & Hamidreza Ghandehari. (2012) Polymeric Conjugates for Drug Delivery. Chemistry of Materials 24:5, pages 840-853.
Crossref
Crossref
Dong-Hee Na. (2011) Development of Protein Drugs by PEGylation Technology. KSBB Journal 26:4, pages 293-299.
Crossref
Crossref
Erika Hubina, Ágnes Tóth, Gábor László Kovács, Judit Dénes, László Kovács & Miklós Góth. (2011) Growth hormone receptor antagonist in the treatment of acromegaly. Orvosi Hetilap 152:18, pages 709-714.
Crossref
Crossref
Alice Thorpe, Helen Freeman, Sarbendra L. Pradhananga, Ian R. Wilkinson & Richard J. M. Ross. 2011. Growth Hormone Related Diseases and Therapy. Growth Hormone Related Diseases and Therapy
361
373
.
Ferdinand RoelfsemaNienke R. BiermaszAlberto M. PereiraJohannes A. Romijn. (2009) Lanreotide Autogel® in the Treatment of Acromegaly. Clinical Medicine. Therapeutics 1, pages CMT.S2150.
Crossref
Crossref
Rory F. Finn. 2009. PEGylated Protein Drugs: Basic Science and Clinical Applications. PEGylated Protein Drugs: Basic Science and Clinical Applications
187
203
.
Francesco M Veronese & Anna Mero. (2008) The Impact of PEGylation on Biological Therapies. BioDrugs 22:5, pages 315-329.
Crossref
Crossref